šŸ‘¤ V R Kovalenko

šŸ” Search šŸ“‹ Browse šŸ·ļø Tags ā¤ļø Favourites āž• Add 🧬 Extraction
2
Articles
2
Name variants
Also published as: Elena Kovalenko,
articles
Aleksandra Berseneva, Elena Kovalenko, Ekaterina Vergasova +8 more Ā· 2023 Ā· European journal of clinical nutrition Ā· Nature Ā· added 2026-04-24
Overweight is the scourge of modern society and a major risk factor for many diseases. For this reason, understanding the genetic component predisposing to high body mass index (BMI) seems to be an im Show more
Overweight is the scourge of modern society and a major risk factor for many diseases. For this reason, understanding the genetic component predisposing to high body mass index (BMI) seems to be an important task along with preventive measures aimed at improving eating behavior and increasing physical activity. We analyzed genetic data of a European cohort (n = 21,080, 47.25% women, East Slavs ancestry >80%) for 5 frequently found genes in the context of association with obesity: IPX3 (rs3751723), MC4R (rs17782313), TMEM18 (rs6548238), PPARG (rs1801282) and FTO (rs9939609). Our study revealed significant associations of FTO (rs9939609) (β = 0.37 (kg/m The results confirm the contribution of FTO, M4CR, and TMEM18 genes to the mechanism of body weight regulation and control. Show less
no PDF DOI: 10.1038/s41430-023-01265-z
MC4R
E V Dementyeva, S P Medvedev, V R Kovalenko +6 more Ā· 2019 Ā· Biochemistry. Biokhimiia Ā· added 2026-04-24
Generation of patient-specific induced pluripotent stem cells (iPSCs) and their subsequent differentiation into cardiomyocytes opened new opportunities for studying pathogenesis of inherited cardiovas Show more
Generation of patient-specific induced pluripotent stem cells (iPSCs) and their subsequent differentiation into cardiomyocytes opened new opportunities for studying pathogenesis of inherited cardiovascular diseases. One of these diseases is hypertrophic cardiomyopathy (HCM) for which no efficient therapy methods have been developed so far. In this study, the approach based on patient-specific iPSCs was applied to create a model of the disease. Genetic analysis of a hypertrophic cardiomyopathy patient revealed R326Q mutation in the MYBPC3 gene. iPSCs of the patient were generated and characterized. The cells were differentiated into cardiomyocytes together with the control iPSCs from a healthy donor. The patient's iPSC-derived cardiomyocytes exhibited early HCM features, such as abnormal calcium handling and increased intracellular calcium concentration. Therefore, cardiomyocytes obtained by directed differentiation of iPSCs from the HCM patient can be used as a model system to study HCM pathogenesis. Show less
no PDF DOI: 10.1134/S0006297919030118
MYBPC3